Aciclovir: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy AJ Wagstaff, D Faulds, KL Goa Drugs 47, 153-205, 1994 | 483 | 1994 |
Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension KL Goa, AJ Wagstaff Drugs 51, 820-845, 1996 | 408 | 1996 |
Cyclosporin: An Updated Review of the Pharmacokinetic Properties, Clinical Efficacy and Tolerability of a Microemulsion-Based Formulation (Neoral®) su1 in Organ Transplantation CJ Dunn, AJ Wagstaff, CM Perry, GL Plosker, KL Goa Drugs 61 (13), 1957-2016, 2001 | 341 | 2001 |
Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control RBR Muijsers, AJ Wagstaff Drugs 61, 2289-2307, 2001 | 331 | 2001 |
Tranexamic acid: a review of its use in the management of menorrhagia K Wellington, AJ Wagstaff Drugs 63, 1417-1433, 2003 | 316 | 2003 |
Tizanidine: a review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders AJ Wagstaff, HM Bryson Drugs 53, 435-452, 1997 | 298 | 1997 |
Foscarnet: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections AJ Wagstaff, HM Bryson Drugs 48, 199-226, 1994 | 298 | 1994 |
Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus AJ Wagstaff, KL Goa Drugs 62, 1805-1837, 2002 | 287 | 2002 |
Lamotrigine: a review of its use in bipolar disorder DR Goldsmith, AJ Wagstaff, T Ibbotson, CM Perry Drugs 63, 2029-2050, 2003 | 264 | 2003 |
Tianeptine: a review of its use in depressive disorders AJ Wagstaff, D Ormrod, CM Spencer CNS drugs 15, 231-259, 2001 | 248 | 2001 |
Fexofenadine. A Markham, AJ Wagstaff Drugs 55 (2), 1998 | 234 | 1998 |
Meropenem: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy LR Wiseman, AJ Wagstaff, RN Brogden, HM Bryson Drugs 50, 73-101, 1995 | 233 | 1995 |
Carboplatin: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer AJ Wagstaff, A Ward, P Benfield, RC Heel Drugs 37, 162-190, 1989 | 227 | 1989 |
Doxazosin: an update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia B Fulton, AJ Wagstaff, EM Sorkin Drugs 49, 295-320, 1995 | 224 | 1995 |
Clozapine: a review of its pharmacological properties and therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical antipsychotic agents AJ Wagstaff, HM Bryson CNS drugs 4, 370-400, 1995 | 221* | 1995 |
Amlodipine: a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease M Haria, AJ Wagstaff Drugs 50, 560-586, 1995 | 210 | 1995 |
Quetiapine: a review of its use in the management of schizophrenia SM Cheer, AJ Wagstaff CNS drugs 18, 173-199, 2004 | 203 | 2004 |
Carvedilol: a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders CJ Dunn, AP Lea, AJ Wagstaff Drugs 54, 161-185, 1997 | 184 | 1997 |
Famciclovir: a review of its pharmacological properties and therapeutic efficacy in herpesvirus infections CM Perry, AJ Wagstaff Drugs 50, 396-415, 1995 | 183 | 1995 |
Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolemia GL Plosker, AJ Wagstaff Drugs 51, 433-459, 1996 | 182 | 1996 |